Insulet Corporation (PODD) Stock Price

PODDStock
$143.0556.04%52W
Market Cap$9.92B
P/E41.10x
PEG Ratio1.49
Div yield
Beta1.10

PODD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-54.90%
Price vs S&P 500 (4W)-16.22%
PEG Ratio1.49
VGM Score55.31
P/E Ratio (Annual)41.10x

PODD Earnings Surprise History

Q2 251.17est. 0.92
Q3 251.24est. 1.15
Q4 251.55est. 1.46
Q1 261.42est. 1.19
Q2 261.66est. 1.45

PODD Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.18
4.24
4.20
4.18

Industry Peers — Surgical & Medical Instruments(140)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
PODDInsulet Corporation
CAD$143.05
SYKStryker CorporationCBC$330.59
MMM3M CompanyCDB$179.37
BSXBoston Scientific Corp.CBD$49.86
BDXBecton, Dickinson and Co.BDB$189.78
MDLNMedline Inc. Class A common stockCDC$35.64
RMDResMed Inc.CBC$236.59
DXCMDexCom, Inc.DBB$89.16
WSTWest Pharmaceutical Services, Inc.DCB$348.48
SOLVSolventum CorporationCCB$91.61
BAXBaxter International Inc.BDB$26.29

About Insulet Corporation

Insulet manufactures the Omnipod system, a smartphone-controlled, disposable insulin infusion device that simplifies continuous insulin therapy for diabetic patients. FDA-approved since 2005, the system has been adopted by approximately 500,000 patients worldwide, establishing Insulet as a leader in automated insulin delivery solutions.